Supporting regeneration with innovative biomaterials: an interview with Matteo Santin INTERVIEW Research Supporting regeneration with innovative biomaterials: an interview with Matteo Santin RegMedNet Aug 15, 2018
Bridging the gap between academy and industry: an interview with Bruce Levine Member Exclusive INTERVIEW Videos, Manufacturing Bridging the gap between academy and industry: an interview with Bruce Levine RegMedNet Aug 13, 2018
Cell & Gene Therapy Bioprocessing & Commercialization is back Events Cell & Gene Therapy Bioprocessing & Commercialization is back RegMedNet Aug 10, 2018
Cell therapy weekly: Experimental hemophilia gene therapy to progress despite adverse immune response in two patients NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy Cell therapy weekly: Experimental hemophilia gene therapy to progress despite adverse immune response in two patients RegMedNet Aug 09, 2018
PSC-derived neural cells promote spinal cord regeneration News & views PSC-derived neural cells promote spinal cord regeneration RegMedNet Aug 07, 2018
Cancer immunotherapy, regenerative medicine and C3i COMMUNITY POST Spotlight on immunotherapy Cancer immunotherapy, regenerative medicine and C3i RegMedNet Aug 06, 2018
Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective Spotlight on immunotherapy Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective RegMedNet Aug 03, 2018
Cell therapy weekly: Japanese scientists target Parkinson’s disease with iPSC-derived dopaminergic progenitors NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy Cell therapy weekly: Japanese scientists target Parkinson’s disease with iPSC-derived dopaminergic progenitors RegMedNet Aug 02, 2018
Business of regenerative medicine: an expert panel discussion Biobanking, Cell therapy, Industry developments, Manufacturing, Business of regenerative medicine Business of regenerative medicine: an expert panel discussion RegMedNet Jul 31, 2018
Crowdfunding care: an interview with Jeremy Snyder INTERVIEW News & views, Ethics & policy, Regenerative Medicine Crowdfunding care: an interview with Jeremy Snyder RegMedNet Jul 31, 2018
Recent results of immunotherapy and perspectives for advanced NSCLC Spotlight on immunotherapy Recent results of immunotherapy and perspectives for advanced NSCLC RegMedNet Jul 31, 2018
Cell therapy weekly: Severe spinal cord injury trial demonstrates favorable safety and improved motor function NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy Cell therapy weekly: Severe spinal cord injury trial demonstrates favorable safety and improved motor function RegMedNet Jul 26, 2018
Could a small molecule complement regenerative therapies in spinal cord injury? News & views Could a small molecule complement regenerative therapies in spinal cord injury? RegMedNet Jul 25, 2018
News In Brief: The State of the Registry Report 2018 Member Exclusive INFOGRAPHIC NEWS ROUND-UP News & views, Biobanking, Cord blood News In Brief: The State of the Registry Report 2018 RegMedNet Jul 24, 2018
Improving Alzheimer’s disease immunotherapy by increasing entry to brain COMMUNITY POST LONGER READ Spotlight on immunotherapy Improving Alzheimer’s disease immunotherapy by increasing entry to brain RegMedNet Jul 23, 2018
Cell therapy weekly: Novartis faces production glitch over Kymriah NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy Cell therapy weekly: Novartis faces production glitch over Kymriah RegMedNet Jul 19, 2018
Transitioning CAR T-cells from their “comfort zone”: an interview with John Maher INTERVIEW LONGER READ Spotlight on immunotherapy, Cell therapy Transitioning CAR T-cells from their “comfort zone”: an interview with John Maher RegMedNet Jul 18, 2018
Cell therapy weekly: FDA aims to advance gene therapies and T cells reprogrammed without the use of viral vectors NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy, Ethics & policy, Industry developments Cell therapy weekly: FDA aims to advance gene therapies and T cells reprogrammed without the use of viral vectors RegMedNet Jul 12, 2018
Business of regenerative medicine: scalability and sustainability – the facility of the future Business of regenerative medicine Business of regenerative medicine: scalability and sustainability – the facility of the future RegMedNet Jul 09, 2018
Business of regenerative medicine: comparability and the regulatory revolution Business of regenerative medicine Business of regenerative medicine: comparability and the regulatory revolution RegMedNet Jul 09, 2018
Business of regenerative medicine: preservation and the supply chain Business of regenerative medicine Business of regenerative medicine: preservation and the supply chain RegMedNet Jul 09, 2018
The RegMedNet Award for Cultivating Excellence is back! Cell therapy, Research, RegMedNet, RegMedNet Award for Cultivating Excellence The RegMedNet Award for Cultivating Excellence is back! RegMedNet Jul 09, 2018
Registration and abstract submission extended for FIRM 2018 Events Registration and abstract submission extended for FIRM 2018 RegMedNet Jul 09, 2018
Share your thoughts on immunotherapy in our weekly polls! Spotlight on immunotherapy Share your thoughts on immunotherapy in our weekly polls! RegMedNet Jul 08, 2018
Cell therapy weekly: New cord blood technology delivers three times more stem cells NEWS ROUND-UP News & views, Cell therapy, Cord blood Cell therapy weekly: New cord blood technology delivers three times more stem cells RegMedNet Jul 05, 2018
